B7-H3, frequently absent or expressed at low levels in physiological conditions, is overexpressed in a wide range of solid tumors (cervical-, colorectal-, and prostate cancer) and some hematologic malignancies, including AML, Myelodysplastic Syndromes (MDS) and others. This evidence concerns the gene CD276 and acute myeloid leukemia.